Zekai Tahir Burak Maternity Teaching Hospital, Neonatology Unit
Ankara, 06600, Turkey (Türkiye)
NCT Number: NCT01360528
Therefore preterm infants must need folic acid replacement than term babies.
Looking for future studies?
Notify Me24 week–34 week
All sexes
Observational
Ankara, 06600, Turkey (Türkiye)
All babies need to different vitamin supplementation. Especially preterm infants need some vitamin supplements. Folic acid is very important structure of part of cell growing.ın theorically; preterm infants have very rapid cell reproduction capacity than term infants. Therefore preterm infants must need folic acid replacement than term babies. The investigators want to determine preterm infants folic acid levels due to gestational age whether needs folic acid replacement.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
-All preterm infants
Exclusion criteria
-Major congenital anomaly
Mehmet Yekta
Other
Zekai Tahir Burak Maternity and Teaching Hospital
Acronym: FALIPI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06870318
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Death
Toronto, Ontario, Canada
View Trial DetailsNCT06379178
Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications
Sleman, Special Region of Yogyakarta, Indonesia
View Trial DetailsNCT03403530
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases
Bhavnagar, Gujarat, India
View Trial DetailsNCT03214822
Communicable Diseases, Disease Attributes
Winnipeg, Manitoba, Canada
View Trial Details